Familial Hypercholesterolemia: Do HDL Play a Role?
Cardiovascular disease (CVD) in heterozygous familial hypercholesterolemia (HeFH), the most frequent monogenic disorder of human metabolism, is largely driven by low-density lipoprotein (LDL) cholesterol concentrations. Since the CVD rate differs considerably in this population, beyond the lifetime...
Main Authors: | Juan Pedro-Botet, Elisenda Climent, David Benaiges |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/7/810 |
Similar Items
-
Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia
by: Vasilis Tsimihodimos, et al.
Published: (2002-02-01) -
Familial hypercholesterolemia: A review
by: Mithun J Varghese
Published: (2014-01-01) -
LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection
by: Alexina Orsoni, et al.
Published: (2011-12-01) -
Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]
by: Fabiana Rached, et al.
Published: (2014-12-01) -
Monozygotic twins with familial hypercholesterolemia and high lipoprotein(a) levels leading to identical cardiovascular outcomes: Case report and review of the literature
by: Meral Kayıkçıoğlu, et al.
Published: (2020-07-01)